Cell heterogeneity contributes to the variable response of HIV-1 to latency-reversing agents
Rachel Topno, Hussein Karaki, Flavia Mazzarda, Oriane Pourcelot, Manon Philippe, Kazem Zibara, Ovidiu Radulescu, Edouard Bertrand · 2026
Read Cell heterogeneity contributes to the variable response of HIV-1 to latency-reversing agents by Rachel Topno, Hussein Karaki, Flavia Mazzarda, Oriane Pourcelot, Manon Philippe, Kazem Zibara, Ovidiu Radulescu, Edouard Bertrand (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13651875.txt.
Description
Rachel Topno and seven colleagues examine why HIV-1 responds so unevenly to drugs meant to wake the sleeping virus. Using a dual-copy tagging system that lets them watch two viral copies inside one living cell, the team tracked how transcription switches on and off. Their work tackles a core problem in HIV research: hidden viral copies that survive treatment and can restart infection later.
In resting cells, the two copies behaved independently, which points to random promoter activity as the main source of variation. Once latency-reversing drugs were added, copies inside the same cell began to move together, showing that the state of the cell itself took over. That shift helps explain why the same drug wakes the virus in some cells and fails in others, and it gives future cure strategies a clearer target.
Catalog record
| CREATOR | Rachel Topno, Hussein Karaki, Flavia Mazzarda, Oriane Pourcelot, Manon Philippe, Kazem Zibara, Ovidiu Radulescu, Edouard Bertrand |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 62 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |